Aspergillus fumigatus, a ubiquitous pathogen, causes aspergillosis in humans, especially in
immunodeficient patients. Azoles are frontline antifungal drugs for treating aspergillosis. The …

Introduction Advances in diagnostic technologies, particularly Point-of-Care Diagnostics
(POCDs), have revolutionized clinical practice by providing rapid, user-friendly, and …

The number of antifungal classes is small, and resistance is becoming a much more
frequent problem. Much greater emphasis needs to be placed on susceptibility testing and …

Before the outbreak of Coronavirus disease-19, one of the top 10 most risks identified by the
World Health Organization (WHO) is antimicrobial resistance (AMR) that is also known as …

Azole antifungals remain the “gold standard” therapy for invasive aspergillosis. The world-
wide emergence of isolates resistant to this drug class, however, developed into a steadily …

Invasive pulmonary aspergillosis (IPA) caused by the mold Aspergillus fumigatus is one of
the most important life-threatening infections in immunocompromised patients. The alarming …

Background This study aimed to investigate the Aspergillus species distribution, antifungal
sensitivities, clinical characteristics, and risk factors of patients with invasive aspergillosis …

Aspergillus fumigatus is the most common cause of invasive fungal mold infections in
immunocompromised individuals. Current antifungal treatment relies heavily on the triazole …

Aspergillus fumigatus is a ubiquitous environmental mold that can cause severe disease in
immunocompromised patients and chronic disease in individuals with underlying lung …

Fusarium head blight (FHB) caused by Fusarium graminearum is a serious fungal disease
that can dramatically impact wheat production. At present, disease control is mainly …